120 related articles for article (PubMed ID: 9127302)
21. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
Nuttens VE; Lucas S
Med Phys; 2006 Apr; 33(4):1101-7. PubMed ID: 16696487
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources.
Awan SB; Meigooni AS; Mokhberiosgouei R; Hussain M
Med Phys; 2006 Nov; 33(11):4271-9. PubMed ID: 17153405
[TBL] [Abstract][Full Text] [Related]
23. Theoretical analysis of microdosimetric spectra and cluster formation for 103Pd and 125I photon emitters.
Reniers B; Vynckier S; Verhaegen F
Phys Med Biol; 2004 Aug; 49(16):3781-95. PubMed ID: 15446805
[TBL] [Abstract][Full Text] [Related]
24. Two-dimensional dosimetry in the near field of the model 200 103Pd source for interstitial brachytherapy implants using a thermoluminescent sheet.
Iwata K; Yue NJ; Nath R
Phys Med Biol; 2004 Sep; 49(17):4049-63. PubMed ID: 15470922
[TBL] [Abstract][Full Text] [Related]
25. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
26. Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.
Meigooni AS; Awan SB; Rachabatthula V; Koona RA
J Appl Clin Med Phys; 2005; 6(3):23-36. PubMed ID: 16143789
[TBL] [Abstract][Full Text] [Related]
27. Improved treatment planning for COMS eye plaques.
Astrahan MA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalism.
Wallace RE; Fan JJ
Med Phys; 1998 Nov; 25(11):2190-6. PubMed ID: 9829244
[TBL] [Abstract][Full Text] [Related]
29. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source.
Li Z; Palta JR; Fan JJ
Med Phys; 2000 May; 27(5):1108-12. PubMed ID: 10841416
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
Meigooni AS; Sowards K; Soldano M
Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
[TBL] [Abstract][Full Text] [Related]
31. Near-field dosimetry of 125I sources for interstitial brachytherapy implants measured using thermoluminescent sheets.
Iwata K; Yue NJ; Nath R
Med Phys; 2004 Dec; 31(12):3406-16. PubMed ID: 15651623
[TBL] [Abstract][Full Text] [Related]
32. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
33. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
[TBL] [Abstract][Full Text] [Related]
34. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.
Nath R; Anderson LL; Luxton G; Weaver KA; Williamson JF; Meigooni AS
Med Phys; 1995 Feb; 22(2):209-34. PubMed ID: 7565352
[No Abstract] [Full Text] [Related]
35. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
Monroe JI; Williamson JF
Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
[TBL] [Abstract][Full Text] [Related]
36. A Monte Carlo brachytherapy study for dose distribution prediction in an inhomogeneous medium.
Slate LJ; Elson HR; Lamba MA; Kassing WM; Soldano M; Barrett WL
Med Dosim; 2004; 29(4):271-8. PubMed ID: 15528069
[TBL] [Abstract][Full Text] [Related]
37. The use of anisotropic data in 125I prostate implants.
Fox RA; Haworth A; Mina LL
Australas Phys Eng Sci Med; 1997 Jun; 20(2):57-63. PubMed ID: 9262024
[TBL] [Abstract][Full Text] [Related]
38. A radiobiological investigation on dose and dose rate for permanent implant brachytherapy of breast using 125I or 103Pd sources.
Baltas D; Lymperopoulou G; Löffler E; Mavroidis P
Med Phys; 2010 Jun; 37(6):2572-86. PubMed ID: 20632569
[TBL] [Abstract][Full Text] [Related]
39. On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources.
Chan GH; Nath R; Williamson JF;
Med Phys; 2004 May; 31(5):1040-5. PubMed ID: 15191290
[TBL] [Abstract][Full Text] [Related]
40. Calculation of the 3-D dose distribution surrounding a 103Pd stent.
McLemore LB; Horton JL; Antolak JA
Cardiovasc Radiat Med; 2001; 2(3):181-90. PubMed ID: 11786325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
